Ftse Mib
36.143,83
-0,34%
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
101.522,61
-0,49%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ INmune Bio Inc (INMB) INmune Bio Inc (INMB) Notizie

INmune Bio Inc

INMB
6,50
-0,22 (-3,27%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202521:41EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
09/12/202422:05EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
09/12/202422:00EDGAR2Form 8-K - Current report
09/12/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:00EDGAR2Form 8-K - Current report
13/11/202412:08EDGAR2Form 8-K - Current report
01/11/202421:23EDGAR2Form 8-K - Current report
31/10/202421:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/10/202421:00EDGAR2Form 8-K - Current report
25/10/202422:00EDGAR2Form 8-K - Current report
24/10/202422:00EDGAR2Form 8-K - Current report
11/10/202422:00EDGAR2Form 8-K - Current report
26/9/202422:00EDGAR2Form 8-K - Current report
17/9/202422:00EDGAR2Form 8-K - Current report
17/9/202402:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202416:15EDGAR2Form 8-K - Current report
16/9/202416:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/9/202422:00EDGAR2Form 8-K - Current report
09/8/202422:10EDGAR2Form 8-K - Current report
09/8/202422:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/8/202422:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
02/8/202422:00EDGAR2Form 8-K - Current report
01/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202422:00EDGAR2Form 8-K - Current report
19/7/202422:00EDGAR2Form 8-K - Current report
13/6/202422:05EDGAR2Form 8-K - Current report
12/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:00EDGAR2Form 8-K - Current report
30/5/202414:00GLOBEINmune Bio Inc. to Join Russell 3000® Index
29/5/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
23/5/202422:00EDGAR2Form 8-K - Current report
16/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:00EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEINmune Bio Inc. Announces First Quarter 2024 Results and..
07/5/202414:00GLOBEINmune Bio Inc. to Report First Quarter 2024 Financial..
30/4/202414:00GLOBEINmune Bio Inc. Provides Update on Two Patients from the..
29/4/202414:00GLOBEINmune Bio Inc. Completes First Cohort and Initiates Second..
25/4/202415:00GLOBEINmune Bio Inc. Announces $9.7 Million Registered Direct..
23/4/202414:00GLOBEINmune Bio Inc. Announces 24-Month Stability Validation of..
22/4/202414:00GLOBEINmune Bio Inc. Raises Approximately $4.8 Million in Gross..
08/4/202414:00GLOBEINmune Bio Inc. Presents Data on INB03’s Role as an Immune..
Apertura: 6,74 Min: 6,035 Max: 6,80
Chiusura: 6,72

La tua Cronologia

NASDAQ
INMB
INmune Bio
BIT
FAMTEL
Msci World Info Tech Esg...
ASX
PIM
Pinnacle Minerals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network